StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
TWSTTwist Bioscience Corp
stockpulse.co.kr
Nasdaq
$138.88▼ 0.76%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $8.65BShares out 62.3M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

106
  • 1d agoRegular26.10.24 04:15
    144Ownership#●●●#●●●

    Twist Bioscience Corp

    Twist Bioscience Corp insider Finn Patrick John has filed a Form 144 to report a proposed sale of company shares. This is a standard filing disclosing the insider's plan to dispose of their holdings.…more

    $138.88-0.76%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 10.13After-hours26.10.14 05:05
    4Ownership

    Twist Bioscience Corp

    Insider Adam Laponis of Twist Bioscience Corp reported a change in beneficial ownership of securities effective October 9, 2026. This filing provides the details of the insider's equity transaction via Form 4.…more

    $138.88-0.76%vs prev close
    View filingShare
  • 10.9Regular26.10.10 04:12
    144Ownership

    Twist Bioscience Corp

    Adam Laponis, an insider at Twist Bioscience Corp, has filed Form 144 to report a proposed sale of company shares. This filing serves as a formal notification of the executive's plan to dispose of his holdings.…more

    $138.88-0.76%vs prev close
    View filingShare

105 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 9.16Regular26.09.16 23:59
    #●●●#●●●#●●●

    Twist Bioscience Partners With Eli Lilly's TuneLab AI Drug Discovery Platform…more

    Twist Bioscience has entered into an agreement to provide antibody characterization data services for Eli Lilly's AI-driven drug discovery platform, TuneLab. This partnership allows users to integrate high-quality wet lab data into TuneLab's models to accelerate the selection of drug candidates.…more

    $138.88-0.76%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    ShareBenzinga
  • 9.16Pre-market26.09.16 21:04

    ●●●●●●●● ●●●●● ●●●●●●

    Twist Bioscience has entered into an agreement with Lilly TuneLab to advance antibody drug discovery efforts. As no specific financial terms or contract values were disclosed, the impact remains to be seen.…more

    $138.88-0.76%vs prev close
    ShareBenzinga
  • 8.19Regular26.08.20 02:46

    ●●●●●●●● ●●●●● ●●●●●●

    Twist Bioscience stock reached a 52-week high after being selected by Anthropic to validate proteins designed by its AI models. This partnership highlights the company's growing role in the AI-driven drug discovery and life sciences research sector.…more

    $138.88-0.76%vs prev close
    ShareBenzinga

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →